Connect with us

Health

What Is So Distinct About InMed Pharmaceuticals, Inc. (OTCMKTS:IMLFF)?

Published

on

NetworkNewsWire reported the publication of an article showcasing work of InMed Pharmaceuticals, Inc. (OTCMKTS:IMLFF), a client of NNW focused on the advancement of novel therapeutics using the pharmacological benefits of cannabinoids.

The details

The publication highlights biotech firms creating cannabis-based offerings to cure numerous medical disorders through the advancement of high-tech extraction methods. CBD is merely one compound out of over 90 found within the cannabis crop, though. While several firms with an interest in medical marijuana follow different avenues to extract CBDs, InMed Pharmaceuticals has advanced a proprietary procedure capable of extracting all more than 90 cannabinoids in a laboratory environment, eliminating most of the costly needs that usually come with cannabinoid extraction.

InMed’s unique process targets considerable cost savings and enhanced production, quality control and purification compared to current grow-harvest-extract-purify processes employed by other firms. With similar scientific processes used in numerous pharmaceutical applications, the company’s biosynthesis system will enable the extraction of all of the over 90 naturally occurring cannabinoids.

Its proprietary biopharmaceutical mechanism to the manufacturing of pharmaceutical grade, bio-identical CBDs is a transformative technology in the fast growing CBD pharmaceutical, medicinal and nutraceutical divisions.

On the cusp of transforming cannabinoid extraction, InMed is gathering the world’s top experts to assist with progressing its biosynthesis know-how toward commercialization. In September, the company retained Ben Paterson, P.E. as an advisor to help outline the pathway for the purification, manufacturing and scale-up plans for company’s cannabinoid biosynthesis program.

NetworkNewsWire is an information service that offers access to news aggregation and syndication servers; summarizes corporate updates and information; improved press release services; social media optimization and distribution services; and a full suite of corporate communication solutions. As a distinct financial news and content distribution firm with an extensive team of contributing writers and journalists, NNW is well positioned to serve public and private firms that intend to reach a wide audience of journalists, investors, consumers and the general public.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement
Advertisement

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement